CRMD 10-Q: SEC filing

CorMedix Inc.

Filed with the SEC on · accession 0001410098-26-000067

CRMD filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +1.0% by the first close after the filing.

Summary of the filing

CorMedix Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue, expenses, and customer concentration disclosures.

Key details

FilerCorMedix Inc.

How CRMD stock reacted

Close before

$5.30

Nov 11, 2026

First close after

+1.04%

$5.36

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CRMD, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CRMD?

Click here

Frequently asked questions

What did CRMD file with the SEC on Nov 12, 2026?

CRMD filed a 10-Q (SEC filing). CorMedix Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue, expenses, and customer concentration disclosures.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did CRMD stock react to this filing?

CRMD closed at $5.30 before the filing and $5.36 on Nov 12, 2026 (+1.04%).

Other CRMD SEC filings

Get alerts when CRMD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days